Government, drugmakers poles apart on drug price reform

The government and domestic drug firms remain far apart in their positions over the latter’s plan to cut drug prices by an average of 17 percent starting next year, which has triggered vehement protests from the domestic pharmaceutical community.

In a forthcoming meeting on September 30, Health and Welfare Minister-nominee Rim Che-min will seek an open dialogue with the representative from t...